Neuroimaging in Mitochondrial Disorders

Neurotherapeutics

Volumn 10, Issue 2, 2013, Pages 273-285

  Gropman, Andrea L ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Brain injury; diffusion tensor imaging (DTI); functional MRI (fMRI); inborn error of metabolism; magnetic resonance imaging (MRI); magnetic resonance spectroscopy (MRS); metabolism; mitochondrial disorder.

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; TRANSFER RNA; UBIQUINOL CYTOCHROME C REDUCTASE;

BRAIN CORTEX ATROPHY; BRAIN INFARCTION; CENTRAL NERVOUS SYSTEM; CEREBELLUM ATROPHY; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; DEMYELINATION; DENTATE NUCLEUS; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPILEPSY; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; IN VIVO STUDY; LEIGH DISEASE; LEUKODYSTROPHY; MELAS SYNDROME; MITOCHONDRIAL ENCEPHALOPATHY; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PURKINJE CELL; RESPIRATORY CHAIN; REVIEW; SIGNAL NOISE RATIO; VOXEL BASED MORPHOMETRY; WHITE MATTER INJURY;

EID: 84876196884     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-012-0161-6     Document Type: Review

References (80)

1. Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol Mech Dis 2010; 5: 297-348.
2. DiMauro S. Mitochondrial medicine. Biochim Biophys Acta 2004; 1658: 107-114.
3. Thorburn DR. Mitochondrial disorders: prevalence, myths, and advances. J Inherit Metab Dis 2004; 27: 349-362.
4. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-465.
5. Dimauro S. A history of mitochondrial diseases. J Inherit Metab Dis 2011; 34: 261-276.
6. Gropman AL. The neurological presentations of childhood and adult mitochondrial disease: established syndromes and phenotypic variations. Mitochondrion 2004; 4: 503-520.
7. Brunetti-Pierri N, Selby K, O'Sullivan M, et al. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI. Neuropediatrics 2008; 39: 179-183.
8. Haas R, Dietrich R. Neuroimaging of mitochondrial disorders. Mitochondrion 2004; 4: 471-490.
9. Friedman SD, Shaw DW, Ishak G, Gropman AL, Saneto RP. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 2010; 16: 129-135.
10. Masucci JP, Schon EA, King MP. Point mutations in the mitochondrial tRNA(Lys) gene: implications for pathogenesis and mechanism. Mol Cell Biochem 1997; 174: 215-219.
11. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283: 1482-1488.
12. Gropman AL. Expanding the diagnostic and research toolbox for inborn errors of metabolism: the role of magnetic resonance spectroscopy. Mol Genet Metab 2005; 86: 2-9.
13. Gelfand JM, Duncan JL, Racine CA, et al. Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol 2011; 258: 440-448.
14. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994; 66: 259-267.
15. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996; 111: 209-219.
16. Ross BD, Bluml S. New aspects of brain physiology. NMR Biomed 1996; 9: 279-296.
17. Guye M, Bartolomei F, Ranjeva JP. Imaging structural and functional connectivity: towards a unified definition of human brain organization? Curr Opin Neurol 2008; 21: 393-403.
18. Iwata O, Iwata S, Tamura M, et al. Periventricular low intensities on fluid attenuated inversion recovery imaging in the newborn infant: Relationships to chronic white matter lesions. Pediatr Int 2004; 46: 141-149.
19. Maillard P, Carmichael O, Harvey D, et al. FLAIR and Diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR 2012. doi: 10. 3174/ajnr. A3146.
20. Hoisington L, Miller RA, Vreibel B. Fast FLAIR techniques in MR imaging of the brain. Radiol Technol 1998; 69: 351-357.
21. Barkovich AJ, Kjos BO, Jackson DE Jr, Norman D. Normal maturation of the neonatal and infant brain: MR imaging at 1. 5 T. Radiology 1988; 16: 173-180.
22. Roy CS, Sherrington CS. On the regulation of the blood supply of the brain. J Physiol 1890; 11: 85-108.
23. Logothetis NK. What we can do and what we cannot do with fMRI. Nature 2008; 453: 869-878.
24. Ashburner J, Friston K. Voxel-based morphometry - the methods. NeuroImage 2000; 11: 805-821.
25. Xu V, Chan H, Lin AP, et al. MR spectroscopy in diagnosis and neurological decision-making. Semin Neurol 2008; 28: 407-422.
26. Panigrahy A, Nelson MD Jr, Blüml S. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 2010; 40: 3-30.
27. Wilichowski E, Pouwels PJ, Frahm J, Hanefeld. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999; 30: 256-263.
28. Dinopoulos A, Cecil KM, Schapiro MB, et al. Brain MRI and proton MRS findings in infants and children with respiratory chain defects. Neuropediatrics 2005; 36: 290-301.
29. Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR 2003; 24: 33-41.
30. Abe K, Yoshimura H, Tanaka H, et al. Comparison of conventional and diffusion weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology 2004; 46: 113-117.
31. Bianchi MC, Sgandurra G, Tosetti M, et al. Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosci Rep 2007; 27: 69-85.
32. Bianchi MC, Tosetti M, Battini R, et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. Am J Neuroradiol 2003; 24: 1958-1966.
33. Pouwels PJ, Brockmann K, Kruse B, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999; 46: 474-485.
34. Bluml S, Seymour KJ, Ross BD. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled 31PMRS in in-vivo human brain. Magn Reson Med 1999; 42: 643-654.
35. Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR 1993; 14: 1119-1137.
36. Barragan-Campos HM, Vallee JN, Lo D, et al. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch Neurol 2005; 62: 737-742.
37. Medina L, Chi TL, DeVivo DC, Hilal SK. MR findings in patients with subacute necrotizing encephalomyelopathy (Leigh syndrome): correlation with biochemical defect. Am J Roentgenol 1990; 154: 1269-1274.
38. Lee HF, Tsai CR, Chi CS, Lee HJ, Chen CC. Leigh syndrome: clinical and neuroimaging follow-up. Pediatr Neurol 2009; 40: 88-93.
39. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951; 14: 216-221.
40. Cavanagh JB, Harding BN. Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 1994; 117: 1357-1376.
41. Leshinsky-Silver E, Lebre AS, Minai L, et al. NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement. Mol Genet Metab 2009; 97: 185-189.
42. Farina L, Chiapparini L, Uziel G, Bugiani M, Zeviani M, Savoiardo M. MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. AJNR 2002; 23: 1095-1100.
43. Hirano M, Ricci E, Koenigsberger MR, et al. MELAS: an original case and clinical criteria for diagnosis. Neuromuscular Disord 1992; 2: 125-135.
44. Wong LJ. Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 2010; 16: 154-162.
45. Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991; 41: 1043-1046.
46. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR 1995; 16: 233-239.
47. Renard D, Bonnaure H, Labauge P. Teaching neuroImages: diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes. Neurology 2010; 75: e9.
48. Finsterer J, Barton P. Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord 2010; 12: 330-334.
49. Ishak GE, Poliakov AV, Poliachik SL, et al. Tract-based spatial statistical analysis of diffusion tensor imaging in pediatric patients with mitochondrial disease: widespread reduction in fractional anisotropy of white matter tracts. AJNR 2012. doi: 10. 3174/ajnr. A3045.
50. Brockmann K, Finsterbusch J, Schara U, Wilichowski E, Frahm J, Hanefeld F. Stroke-like pattern in DTI and MRS of childhood mitochondrial leukoencephalopathy. Neuroradiology 2004; 46: 267-271.
51. Liu Z, Liu X, Hui L, et al. The appearance of ADCs in the non-affected areas of the patients with MELAS. Neuroradiology 2011; 53: 227-232.
52. Clark JM, Marks MP, Adalsteinsson E, et al. MELAS: clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 1996; 46: 223-227.
53. Feng F, You H, Gao J, et al. Evaluation of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with magnetic resonance imaging and proton magnetic resonance spectroscopy. Chin Med Sci J 2006; 21: 234-238.
54. Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987; 74: 226-233.
55. Lim BC, Park JD, Hwang H, et al. Mutations in ND subunits of complex I are an important genetic cause of childhood mitochondrial encephalopathies. J Child Neurol 2009; 24: 828-832.
56. Castro-Gago M, Gonzalez-Conde V, Fernandez-Seara MJ, et al. [Early mitochondrial encephalomyopathy due to complex IV deficiency consistent with Alpers-Huttenlocher syndrome: report of two cases]. Rev Neurol 1999; 29: 912-917.
57. Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004; 114: 925-931.
58. Scaglia F, Wong LJ, Vladutiu GD, Hunter JV. Predominant cerebellar volume loss as a neuroradiologic feature of pediatric respiratory chain defects. AJNR 2005; 26: 1675-1680.
59. Valanne L, Ketonen L, Majander A Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. AJNR 1998; 9: 369-377.
60. Lincke CR, van den Bogert C, Nijtmans LG, Wanders RJ, Tamminga P, Barth PG. Cerebellar hypoplasia in respiratory chain dysfunction. Neuropediatrics 1996; 27: 216-218.
61. Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 1990; 5: 273-287.
62. Hatten HP Jr. Dysmyelinating leukodystrophies: LACK Proper Myelin. Pediatr Radiol 1991; 21: 477-482.
63. Finsterer J. Central nervous system imaging in mitochondrial disorders. Can J Neurol Sci 2009; 36: 143-153.
64. Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion 2008; 8: 396-413.
65. Weinstock A, Giglio P, Cohen ME, Bakshi R, Januario J, Balos L. Diffuse magnetic resonance imaging white matter changes in a 15-year-old boy with mitochondrial encephalomyopathy. J Child Neurol 2002; 17: 47-49.
66. Burgeois M, Goutieres F, Chretien D, Rustin P, Munnich A, Aicardi J. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev 1992; 14: 404-408.
67. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 689-692.
68. Shaibani A, Shchelochkov OA, Zhang S, et al. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 2009; 66: 1028-1032.
69. Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage 2012; 60: 340-352.
70. Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. Am J Neuroradiol 1998; 19: 369-377.
71. Wolf NI, Seitz A, Harting I, et al. New pattern f brain MRI lesions in isolated complex deficiency. Neuropediatrics 2003; 34: 156-159.
72. Munnich A, Rustin P, Rotig A, et al. Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet (Semin Med Genet) 2001; 106: 4-17.
73. Haas RH, Parikh S, Falk MJ, et al. The indepth evaluation of suspected mitochondrial disease. Mol Genet Metab 208; 94: 16-37.
74. Walker UA, Collins S, Byrne E. Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol 1996; 36: 260-267.
75. Wolf NI, Smeitink JA. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 2002; 59: 1402-1405.
76. Morava E, van den Heuvel L, Hol F, et al. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006; 67: 1823-1826.
77. van der Knaap MS, Valk J, de Neeling N, Nauta JJ. Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology 1991; 33: 478-493.
78. Wray SH, Provenzale JM, Johns DR, Thulborn KR. MR of the brain in mitochondrial myopathy. Am J Neuroradiol 1995; 16: 1167-1173.
79. Cakmakci H, Pekcevik Y, Yis U, Unalp A, Kurul S. Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature. Eur J Radiol 2010; 74: e161-e171.
80. Bernier FP, Boneh A, Dennett X, Chow CW, Clearly MA, Thorburn DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002; 59: 1406-1411.